CRELUX GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CRELUX GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3400
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Crelux GmbH (Crelux), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a drug discovery company that discovers drug solutions for pharmacy, biotech and research organizations. The company offers customized and integrated services in areas of drug discovery, X-ray crystallography, protein supply, biophysical analysis and fragment screening. It develops fragment screening platform, which include measurements of enzymatic activities, Kon and off binding kinetics, KD analyses and stability determination of proteins. Crelux’s X intract biophysical analytics and screening platform is made of a versatile series of orthogonal assay technologies for hit validation. The company offers services to support small and large molecules in biopharmaceutical products. Crelux is headquartered in Martinsried, Germany.

CRELUX GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CRELUX GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CRELUX GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
AiCuris Enters Into Drug Discovery Agreement With 4SC Discovery And Crelux 10
UCB Enters Into Drug Discovery Agreement With Crelux And 4SC Discovery 12
4SC Enters Into Co-Development Agreement With Crelux And Ribological 13
Acquisition 14
WuXi AppTec Acquires Crelux 14
CRELUX GmbH – Key Competitors 15
CRELUX GmbH – Key Employees 16
CRELUX GmbH – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
CRELUX GmbH, Pharmaceuticals & Healthcare, Key Facts 2
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CRELUX GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CRELUX GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AiCuris Enters Into Drug Discovery Agreement With 4SC Discovery And Crelux 10
UCB Enters Into Drug Discovery Agreement With Crelux And 4SC Discovery 12
4SC Enters Into Co-Development Agreement With Crelux And Ribological 13
WuXi AppTec Acquires Crelux 14
CRELUX GmbH, Key Competitors 15
CRELUX GmbH, Key Employees 16

List of Figures
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CRELUX GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Republic Services Inc (RSG):企業の財務・戦略的SWOT分析
    Republic Services Inc (RSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ATUM-製薬・医療分野:企業M&A・提携分析
    Summary ATUM, formerly DNA2.0 Inc is a bioengineering company that provide platforms for protein and vector engineering solutions. The company develops and offers synthetic biology solutions. Its products include expression vectors, electra system, CRISPR/Cas9, proteinpaintbox, cell strains and reag …
  • Goa Shipyard Ltd:企業の戦略・SWOT・財務分析
    Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report Summary Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tidewater Inc (TDW):企業の財務・戦略的SWOT分析
    Summary Tidewater Inc (Tidewater) is an an petroleum service company that offers offshore supply vessels and marine support services. The company's services include transport and supply of offshore material; anchor handling, towing and positioning; construction support; well stimulation, FPSO suppor …
  • Syncardia Systems LLC:医療機器:M&Aディール及び事業提携情報
    Summary Syncardia Systems LLC (SynCardia), a subsidiary of Versa Capital Management, Inc. develops and manufactures artificial human heart. Its flagship product, SynCardia temporary Total Artificial Heart (TAH-t) temporarily takes up the complete function of a failed human heart in patients sufferin …
  • Beach Energy Ltd (BPT):企業の財務・戦略的SWOT分析
    Beach Energy Ltd (BPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CLP Holdings Ltd:企業の発電所・SWOT分析2018
    CLP Holdings Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Chi Mei Corp:企業の戦略的SWOT分析
    Chi Mei Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Yuhan Corp (000100):製薬・医療:M&Aディール及び事業提携情報
    Summary Yuhan Corp (Yuhan) researches, develops, manufactures and markets pharmaceutical products. The company offers API's and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, beta-lactase inhibitors, PEGlyated compounds and anti-histamines. …
  • Getlink SE (GET):企業の財務・戦略的SWOT分析
    Getlink SE (GET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • San Juan Basin Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    San Juan Basin Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary San Juan Basin Royalty Trust (SJT) is a trust that has overriding royalty interest divided out of Southland Royalty's oil and gas leasehold and royalty interest in the San Juan Basin of …
  • Asn Bank:企業の戦略・SWOT・財務分析
    Asn Bank - Strategy, SWOT and Corporate Finance Report Summary Asn Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Clariant International Ltd (CLN):企業の財務・戦略的SWOT分析
    Clariant International Ltd (CLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Tokyo Electric Power Company Holdings Incorporated (9501)-石油・ガス分野:企業M&A・提携分析
    Summary Tokyo Electric Power Company Holdings, Incorporated (TEPCO), formerly Tokyo Electric Power Company, Incorporated, is an integrated energy company. The company generates, transmits, distributes and sells electricity through its subsidiaries. It generates power from various sources such as the …
  • Reliance Power Ltd (RPOWER):電力:M&Aディール及び事業提携情報
    Summary Reliance Power Ltd (RPower), formerly Reliance Energy Generation Private Limited, is a power generation and coal resources company. It develops, constructs, and operates power projects and coal mines. The company produces electricity from various sources of electricity including coal, solar …
  • Korea Electric Power Corporation (015760):企業の財務・戦略的SWOT分析
    Korea Electric Power Corporation (015760) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • MannKind Corp (MNKD):製薬・医療:M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …
  • Forendo Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Forendo Pharma Ltd (Forendo Pharma) is a drug development company that concentrates on tissue specific regulation of sex hormone effects. The company’s product pipeline include fispemifene, which is in clinical phase II development and intended for the treatment of lower urinary tract sympto …
  • ModusLink Global Solutions, Inc. (MLNK):企業の財務・戦略的SWOT分析
    ModusLink Global Solutions, Inc. (MLNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆